Multiplicity in randomised trials I: endpoints and treatments
Top Cited Papers
- 1 April 2005
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 365 (9470), 1591-1595
- https://doi.org/10.1016/s0140-6736(05)66461-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Multiplicity in randomised trials II: subgroup and interim analysesThe Lancet, 2005
- Sample size calculations in randomised trials: mandatory and mysticalThe Lancet, 2005
- Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issuesStatistics in Medicine, 2003
- Sifting the evidence---what's wrong with significance tests? Another comment on the role of statistical methodsBMJ, 2001
- Statistics in medical journals: some recent trendsStatistics in Medicine, 2000
- P-Value Interpretation and Alpha Allocation in Clinical TrialsAnnals of Epidemiology, 1998
- What's wrong with Bonferroni adjustmentsBMJ, 1998
- Quantitative Evaluation of Multiplicity in Epidemiology and Public Health ResearchAmerican Journal of Epidemiology, 1998
- Multiple Comparisons and Related Issues in the Interpretation of Epidemiologic DataAmerican Journal of Epidemiology, 1995
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990